Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) fell 1.3% on Thursday . The company traded as low as $67.13 and last traded at $67.54. 1,296 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 4,651 shares. The stock had previously closed at $68.41.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on CZMWY. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Carl Zeiss Meditec in a research note on Tuesday, May 20th. HSBC downgraded shares of Carl Zeiss Meditec to a “reduce” rating in a research note on Tuesday, March 25th. Finally, The Goldman Sachs Group restated a “buy” rating on shares of Carl Zeiss Meditec in a research note on Wednesday, April 16th.
Read Our Latest Research Report on CZMWY
Carl Zeiss Meditec Trading Down 1.3%
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
